J 2010

CORD: COmparison of Recommended Doses of ace inhibitors and angiotensin II receptor blockers.

ŠPINAR, Jindřich, Jiří VÍTOVEC, Miroslav SOUČEK, Ladislav DUŠEK, Tomáš PAVLÍK et. al.

Basic information

Original name

CORD: COmparison of Recommended Doses of ace inhibitors and angiotensin II receptor blockers.

Authors

ŠPINAR, Jindřich (203 Czech Republic, guarantor, belonging to the institution), Jiří VÍTOVEC (203 Czech Republic, belonging to the institution), Miroslav SOUČEK (203 Czech Republic, belonging to the institution), Ladislav DUŠEK (203 Czech Republic, belonging to the institution) and Tomáš PAVLÍK (203 Czech Republic, belonging to the institution)

Edition

International Journal of Cardiology, 2010, 0167-5273

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 6.802

RIV identification code

RIV/00216224:14110/10:00045704

Organization unit

Faculty of Medicine

DOI

UT WoS

000282678300048

Keywords in English

Hypertension; Losartan; Ramipril; Cough

Tags

International impact
Změněno: 8/10/2012 20:45, Mgr. Michal Petr

Abstract

V originále

The CORD trial is the largest trial comparing the antihypertensive effects of ACEI and ARB and confirms that these treatments are safe, effective and well tolerated. Finally, CORD confirms that reaching normal diastolic BP is much easier than controlling systolic BP.

Links

MSM0021622402, plan (intention)
Name: Časná diagnostika a léčba kardiovaskulárních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Early diagnostics and treatment of cardiovascular diseases